The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 6, 2026 | Shukla Abhinav A. | Chief Technical Officer | Option exercise(M) | 12K | $3.57 | $43K |
| Jul 6, 2026 | Shukla Abhinav A. | Chief Technical Officer | Option exercise(M) | 12K | — | $0 |
| Jul 2, 2026 | Shukla Abhinav A. | Chief Technical Officer | Option exercise(M) | 410 | $3.57 | $1K |
| Jul 2, 2026 | Shukla Abhinav A. | Chief Technical Officer | Sell(S) | 410 | $7.01 | $3K |
| Jul 2, 2026 | Shukla Abhinav A. | Chief Technical Officer | Option exercise(M) | 410 | — | $0 |
| Jul 1, 2026 | Shukla Abhinav A. | Chief Technical Officer | Option exercise(M) | 100 | $3.57 | $357 |
| Jul 1, 2026 | Shukla Abhinav A. | Chief Technical Officer | Sell(S) | 100 | $7.07 | $707 |
| Jul 1, 2026 | Shukla Abhinav A. | Chief Technical Officer | Option exercise(M) | 100 | — | $0 |
| Jun 30, 2026 | Shukla Abhinav A. | Chief Technical Officer | Option exercise(M) | 23K | $3.57 | $83K |
| Jun 30, 2026 | Shukla Abhinav A. | Chief Technical Officer | Sell(S) | 23K | $7.08 | $165K |
| Jun 30, 2026 | Shukla Abhinav A. | Chief Technical Officer | Option exercise(M) | 23K | — | $0 |
| Jun 30, 2026 | Pandite Arundathy N. | Chief Medical Officer | Sell(S) | 30K | $7.01 | $210K |
| Jun 11, 2026 | Ashiya Mona | Director | Buy(P) | 1.0M | — | — |
| Jun 11, 2026 | Ashiya Mona | Director | Buy(P) | 208K | — | — |
| Jun 11, 2026 | Orbimed Advisors LLC | Director | Buy(P) | 1.0M | — | — |
| Jun 11, 2026 | Orbimed Advisors LLC | Director | Buy(P) | 208K | — | — |
| Jun 9, 2026 | Siegall Clay B | Director | Buy(P) | 63K | $4.00 | $250K |
| Jun 8, 2026 | Orbimed Advisors LLC | Director | Conversion(C) | 15.4M | — | — |
| Jun 8, 2026 | Orbimed Advisors LLC | Director | Conversion(C) | 3.1M | — | — |
| Jun 8, 2026 | Orbimed Advisors LLC | Director | Conversion(C) | 15.4M | — | — |
| Jun 8, 2026 | Orbimed Advisors LLC | Director | Conversion(C) | 3.1M | — | — |
| Jun 8, 2026 | Ashiya Mona | Director | Conversion(C) | 15.4M | — | — |
| Jun 8, 2026 | Ashiya Mona | Director | Conversion(C) | 3.1M | — | — |
| Jun 8, 2026 | Ashiya Mona | Director | Conversion(C) | 15.4M | — | — |
| Jun 8, 2026 | Ashiya Mona | Director | Conversion(C) | 3.1M | — | — |
| May 29, 2026 | Baker Daniel G. | Director | Grant(A) | 81K | — | $0 |
| May 29, 2026 | Golumbeski George | Director | Grant(A) | 81K | — | $0 |
| May 29, 2026 | Gibson Neil W | Director | Grant(A) | 81K | — | $0 |
| May 29, 2026 | Ashiya Mona | Director | Grant(A) | 81K | — | $0 |
| May 29, 2026 | Siegall Clay B | Director | Grant(A) | 81K | — | $0 |
| May 29, 2026 | Boudreau Helen M | Director | Grant(A) | 81K | — | $0 |
| May 22, 2026 | Siegall Clay B | Director | Grant(A) | 128K | $1.08 | $139K |
| May 22, 2026 | Siegall Clay B | Director | Option exercise(M) | 128K | — | — |
| May 21, 2026 | Shukla Abhinav A. | Chief Technical Officer | Grant(A) | 5K | $1.08 | $6K |
| May 21, 2026 | Shukla Abhinav A. | Chief Technical Officer | Option exercise(M) | 5K | — | — |
| May 15, 2026 | Stout Stephen | See Remarks | Grant(A) | 13K | $1.08 | $14K |
| May 15, 2026 | Stout Stephen | See Remarks | Option exercise(M) | 13K | — | — |
| May 12, 2026 | Schreiber Taylor | Chief Executive Officer, Director | Grant(A) | 26K | $1.08 | $28K |
| May 12, 2026 | Schreiber Taylor | Chief Executive Officer, Director | Option exercise(M) | 26K | — | — |
| May 12, 2026 | Neill Andrew R | Chief Financial Officer | Grant(A) | 64K | $1.08 | $69K |
| May 12, 2026 | Neill Andrew R | Chief Financial Officer | Option exercise(M) | 64K | — | — |
| May 12, 2026 | Pandite Arundathy N. | Chief Medical Officer | Sell(S) | 30K | $6.61 | $198K |
| May 12, 2026 | Shukla Abhinav A. | Chief Technical Officer | Option exercise(M) | 2K | $3.57 | $7K |
| May 12, 2026 | Shukla Abhinav A. | Chief Technical Officer | Sell(S) | 2K | $7.01 | $14K |
| May 12, 2026 | Shukla Abhinav A. | Chief Technical Officer | Option exercise(M) | 2K | — | $0 |
| May 10, 2026 | Stout Stephen | See Remarks | Tax withholding(F) | 968 | $6.85 | $7K |
| Jan 25, 2026 | Neill Andrew R | Chief Financial Officer | Tax withholding(F) | 3K | $4.15 | $11K |
| Jan 25, 2026 | DeYoung Casi | Chief Business Officer | Tax withholding(F) | 2K | $4.15 | $9K |
| Jan 25, 2026 | Stout Stephen | See Remarks | Tax withholding(F) | 593 | $4.15 | $2K |
| Jan 25, 2026 | Pandite Arundathy N. | Chief Medical Officer | Tax withholding(F) | 3K | $4.15 | $13K |
| Jan 10, 2026 | Schreiber Taylor | Chief Executive Officer, Director | Grant(A) | 1.5M | — | $0 |
| Jan 10, 2026 | Neill Andrew R | Chief Financial Officer | Tax withholding(F) | 7K | $4.75 | $32K |
| Jan 10, 2026 | Neill Andrew R | Chief Financial Officer | Grant(A) | 550K | — | $0 |
| Jan 10, 2026 | Pandite Arundathy N. | Chief Medical Officer | Tax withholding(F) | 7K | $4.75 | $33K |
| Jan 10, 2026 | Pandite Arundathy N. | Chief Medical Officer | Grant(A) | 488K | — | $0 |
| Jan 10, 2026 | Shukla Abhinav A. | Chief Technical Officer | Grant(A) | 316K | — | $0 |
| Jan 10, 2026 | DeYoung Casi | Chief Business Officer | Tax withholding(F) | 6K | $4.75 | $27K |
| Jan 10, 2026 | DeYoung Casi | Chief Business Officer | Grant(A) | 382K | — | $0 |
| Jan 10, 2026 | Stout Stephen | See Remarks | Tax withholding(F) | 4K | $4.75 | $20K |
| Jan 10, 2026 | Stout Stephen | See Remarks | Grant(A) | 351K | — | $0 |
| Aug 28, 2025 | Baker Daniel G. | Director | Grant(A) | 66K | — | $0 |
| Aug 28, 2025 | Ashiya Mona | Director | Grant(A) | 66K | — | $0 |
| Aug 25, 2025 | Ashiya Mona | Director | Buy(P) | 1.1M | $0.87 | $914K |
| Aug 25, 2025 | Ashiya Mona | Director | Buy(P) | 5.3M | $0.87 | $4.6M |
| Aug 25, 2025 | Ashiya Mona | Director | Buy(P) | 2.0M | — | — |
| Aug 25, 2025 | Ashiya Mona | Director | Buy(P) | 15.4M | — | — |
| Aug 25, 2025 | Ashiya Mona | Director | Buy(P) | 3.1M | — | — |
| Aug 25, 2025 | Ashiya Mona | Director | Buy(P) | 10.1M | — | — |
| Aug 25, 2025 | OrbiMed Capital GP IX LLC | Director | Buy(P) | 5.3M | $0.87 | $4.6M |
| Aug 25, 2025 | OrbiMed Capital GP IX LLC | Director | Buy(P) | 1.1M | $0.87 | $914K |
| Aug 25, 2025 | OrbiMed Capital GP IX LLC | Director | Buy(P) | 2.0M | — | — |
| Aug 25, 2025 | OrbiMed Capital GP IX LLC | Director | Buy(P) | 10.1M | — | — |
| Aug 25, 2025 | OrbiMed Capital GP IX LLC | Director | Buy(P) | 3.1M | — | — |
| Aug 25, 2025 | OrbiMed Capital GP IX LLC | Director | Buy(P) | 15.4M | — | — |
| Aug 25, 2025 | Green Jeremy | Director, 10% Owner | Grant(A) | 4.1M | — | — |
| Aug 25, 2025 | Green Jeremy | Director, 10% Owner | Grant(A) | 4.1M | — | — |
| Aug 25, 2025 | Shukla Abhinav A. | Chief Technical Officer | Grant(A) | 5K | $0.87 | $4K |
| Aug 25, 2025 | Shukla Abhinav A. | Chief Technical Officer | Grant(A) | 5K | — | — |
| Aug 25, 2025 | Siegall Clay B | Director | Grant(A) | 128K | $0.87 | $111K |
| Aug 25, 2025 | Siegall Clay B | Director | Grant(A) | 128K | — | — |
| Aug 25, 2025 | Stout Stephen | See Remarks | Grant(A) | 13K | $0.87 | $11K |
| Aug 25, 2025 | Stout Stephen | See Remarks | Grant(A) | 13K | — | — |
| Aug 25, 2025 | Schreiber Taylor | Chief Executive Officer, Director | Grant(A) | 26K | $0.87 | $22K |
| Aug 25, 2025 | Schreiber Taylor | Chief Executive Officer, Director | Grant(A) | 26K | — | — |
| Aug 25, 2025 | Neill Andrew R | Chief Financial Officer | Grant(A) | 64K | $0.87 | $56K |
| Aug 25, 2025 | Neill Andrew R | Chief Financial Officer | Grant(A) | 64K | — | — |
| Jul 14, 2025 | Boudreau Helen M | Director | Grant(A) | 33K | — | $0 |
| Jul 14, 2025 | Brous Tyler | Director | Grant(A) | 33K | — | $0 |
| Jul 14, 2025 | Brownstein Carrie | Director | Grant(A) | 33K | — | $0 |
| Jul 14, 2025 | Gibson Neil W | Director | Grant(A) | 33K | — | $0 |
| Jul 14, 2025 | Golumbeski George | Director | Grant(A) | 33K | — | $0 |
| Jul 14, 2025 | Sasser Amy Kate | Director | Grant(A) | 33K | — | $0 |
| Jul 14, 2025 | Siegall Clay B | Director | Grant(A) | 33K | — | $0 |
| Jul 14, 2025 | Redmile Group, LLC | Director, 10% Owner | Grant(A) | 33K | — | $0 |
| Jul 14, 2025 | Lee Michael Stewart | Director | Grant(A) | 33K | — | $0 |
| Jan 28, 2025 | Schreiber Taylor | Chief Executive Officer, Director | Grant(A) | 685K | — | $0 |
| Jan 28, 2025 | Neill Andrew R | Chief Financial Officer | Grant(A) | 214K | — | $0 |
| Jan 28, 2025 | Stout Stephen | See Remarks | Grant(A) | 177K | — | $0 |
| Jan 28, 2025 | Pandite Arundathy N. | Chief Medical Officer | Grant(A) | 206K | — | $0 |
| Jan 28, 2025 | DeYoung Casi | Chief Business Officer | Grant(A) | 194K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-01-04 → 2026-07-21. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).